Evidence map›Paper›PMID 32712932›Full record

ArticleTechniques in coloproctology2021

Superior rectal artery embolization for bleeding internal hemorrhoids.

X Han, F Xia, G Chen, Y Sheng, W Wang, Z Wang, M Zhao, X Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Techniques in coloproctology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Outpatient Transradial Emborrhoid Technique: A Pilot Study.Cardiovascular and interventional radiology · 2021
    Observational
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

X Han *Department of Interventional Medicine and Vascular, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China.
F Xia *Department of Interventional Medicine and Vascular, Binzhou Peoples Hospital, Binzhou, 256600, Shandong, People's Republic of China.
G ChenDepartment of Interventional Medicine and Vascular, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China.
Y ShengDepartment of Interventional Medicine and Vascular, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China.
W WangDepartment of Interventional Medicine and Vascular, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China.
Z WangDepartment of Interventional Medicine and Vascular, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China.
M ZhaoDepartment of Interventional Medicine and Vascular, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China.
X WangDepartment of Gastroenterology, Binzhou Medical University Hospital, No.661 Huanghe 2nd Road, Binzhou, 256603, Shandong, People's Republic of China. wangxuemin0116@163.com.ORCID http://orcid.org/0000-0001-9133-1320
Binzhou Medical University · CNBinzhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of the present study was to evaluate clinical efficacy and safety of superselective embolization of the superior rectal artery (SRA) for the treatment of internal hemorrhoidal bleeding.

methodsPatients with stage II and stage III internal hemorrhoids, treated by interventional embolization of the SRA in our department between January 2017 and June 2019 were retrospectively evaluated. All patients suffering from disabling chronic hematochezia and some with relative contraindications for operation (n = 17) or rejection of conventional hemorrhoidectomy (n = 15). Superselective SRA branch embolization was performed using gelatin sponge particles (350-560 μm) and metallic coils (2-3 mm). This treatment process was planned by a multidisciplinary team consisting of proctologist, gastroenterologist and radiologist. The surgical efficacy, postoperative complications and follow-up outcomes were observed.

resultsThere were 32 patients (18 males, mean age 52 ± 12 years, range: 22-78 years), 12 (37%) with stage II hemorrhoids and 20 (63%) with stage III hemorrhoids. Embolization was successful in all patients, and bleeding symptoms resolved in 27 (84.4%) patients. The remaining 5 (15.6%) patients underwent either stapled hemorrhoidopexy (n = 4) or sclerotherapy (n = 1). Some patients experienced different degrees of pain (n = 4;12.5%), low fever (n = 11;34.4%), and tenesmus (n = 17;53.1%), which all spontaneously regressed without further treatment. All patients were followed up for at least 1 year. There were no serious complications, such as infection, intestinal ischemia or massive hemorrhage. Four patients (14.8%) had rebleeding during the first months of follow-up. All patients with re-bleeding were successfully treated with internal iliac arteriography and branch embolization and did not experience further bleeds after a minimum follow up 3 months follow-up.

conclusionsThe short-term efficacy of superselective SRA embolization for grade II-III internal hemorrhoids is good, and this method is safe and feasible.

Indexed as

Embolization, TherapeuticHemorrhoidsAdultFemaleGastrointestinal HemorrhageHumansMaleMesenteric Artery, InferiorMiddle AgedRetrospective StudiesTreatment OutcomeAngiographyEmbolizationHemorrhoidsInterventionSuperior rectal artery

Identifiers

PMID32712932
OpenAlexW3043843645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.